Archimed
Archimed
ARCHIMED is focused on accelerating the development of healthcare industries and solutions to the benefit of people and patients around the world.
- Use:
- Date closing: -
- Amount: 10M € - 1.00B €
- Industry focus: Health;
- Total budget: 650M €
- Entity type: Private Equity Firm
- Vertical focus: All
- Website: https://www.archimed.group/
- Status: Open
- Funding type: Equity investment;
- Geographic focus:
- Public/Private: Private
- Stage focus:
- Applicant target: Startup;
Overview
ARCHIMED is a global investment firm focused on the healthcare industries. They are joining forces with scientists, healthcare professionals, entrepreneurs, and investors to positively impact companies operating in those fields. They are particularly focused on supporting them in their efforts in internationalization, capacity increase, product range expansion and acquisitions.
They fund, support and scale companies whose activities contribute to improve health outcomes at all levels. Their focused is on small-cap and mid-cap growth buyout transactions with companies operating in one of our seven targeted sectors within healthcare. Through their various fund lines, they invest between 10 million and 1 billion euros in leading companies, always backing the corresponding management teams.
ArchiMed has raised a total of €1.4B across 5 funds, their latest being MED III. This fund was announced on Aug 5, 2021 and raised a total of €650M.
Portfolio: Bomi, Groupe Carso, Ad Tech, Fytexia.
Archimed FAQ
Archimed Reviews
Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
Archimed News
Featured Funds
- Usage: Go2Market;
- Entity type: Venture Capital
- Funding type: Equity investment;
- Status: Open
- Geographic focus: Nordics; Baltics;
- 0 reviews 0 questions
- Usage: Go2Market;
- Entity type: Venture Capital
- Total: 50M €
- Funding type: Loan;
- Status: Open
- Geographic focus: Sweden;
- 0 reviews 0 questions
- Usage: R&D; Go2Market;
- Entity type: Foundation
- Total: 820M €
- Funding type: Loan; Equity investment; Blended finance;
- Status: Open
- Geographic focus: EU;
- 0 reviews 3 questions